The biology of disc degeneration is complex. Some remarkable advances in molecular and cellular biology have recently been achieved in this rapidly evolving field and biological technologies for intervertebral disc repair are currently being developed. In this Viewpoint, Dr Peng discusses the problems that need to be resolved before these technologies can advance from the laboratory to clinical trials.
